Latest Regenerative Neurology News

Subscribe

NurExone Granted U.S. Patent for Exosome Manufacturing Process, Enhancing Supply Chain Capabilities

NurExone secures U.S. patent protection for its exosome production method, supporting scale-up and clinical supply chain readiness.

Hope Biosciences Awarded FDA RMAT Designation for Multiple Sclerosis Stem Cell Therapy

The FDA designation follows promising Phase II trial results for Hope Biosciences’ stem cell therapy in relapsing-remitting multiple sclerosis.

Regenerative Spinal Cord Therapy: Interview with Nurexone Biologic’s CEO, Dr. Lior Shaltiel

Nurexone Biologic has developed an exosome therapy for nerve repair, we interviewed the CEO, Dr. Lior Shaltiel here. Enjoy!

NurExone’s Exosomes Outperform Commercial Standard in Regenerative Study

Independent analysis finds NurExone’s exosomes deliver enhanced regenerative signals, showing promise for nerve repair and tissue healing applications.

Capricor Therapeutics Announces FDA Type A Meeting to Discuss Duchenne Muscular Dystrophy Treatment Path

Capricor Therapeutics is coordinating with the FDA on regulatory steps for its Duchenne therapy, with updates expected soon.

Sumitomo Pharma Submits Application for Japanese Approval of Stem Cell Therapy to Enhance Motor Function in Parkinson’s Disease

Sumitomo Pharma and RACTHERA seek approval for a novel iPS cell-based therapy targeting motor symptoms in advanced Parkinson’s.

Trailhead Biosystems Launches New iPSC-Derived Neurons for Parkinson’s Research

The iPSC-derived A9 dopaminergic neurons will hopefully offer researchers a human-based model for Parkinson’s disease studies.

New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases

Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.

Vita Therapeutics and I Peace Join Forces to Deliver Gene-Edited Stem Cells for Muscular Dystrophy

The companies will collaborate to leverage gene editing and GMP iPSC manufacturing to hopefully deliver new therapies.

Hope Biosciences Launches Phase Ib/IIa Stem Cell Trial for Early Alzheimer’s Disease

Hope Biosciences will study whether stem cell therapy can reduce inflammation or slow Alzheimer’s progression in a new clinical trial.
Load More
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe